Beruflich Dokumente
Kultur Dokumente
http://dx.doi.org/10.1123/ijspp.2016-0421
2016 Human Kinetics, Inc.
INVITED COMMENTARY
974Sanchis-Gomar et al
109
References
Solving this equation, we get ~13 individuals with the required genotype for top-level competition in middle- to long-distance running.
When one considers that an Olympic final will have at most 12
individuals, and if we consider the 1500-m, 3000-m steeplechase,
5000-m, and 10,000 m as representative of middle- to long-distance
running, then at most there are (ignoring overlaps) 52 truly elite
male middle- to long-distance runners on the planet at any given
time, a number that is within 1 order of magnitude of the potential
number of people on the planet (~13) capable of top-class performance. When one considers the circumstances, injuries, political and
economic barriers, and selection into other sports that are likely to
prevent all of the truly top genetic candidates from participating,
the match within 1 order of magnitude of the top sport genomic
equation and Olympic finalists supports the concept that the top
Olympians are likely genetically gifted individuals. Moreover, they
possess numerous contributors to the complex trait of being an
athletic champion that may not depend on defined genetic variations. It seems reasonable to suggest that the genetic requirements
in other sports might be different, although the presence of a large
number of required genes as suggested by Williams and Foland10
is still plausible. Supporting factors required in addition to genetic
predisposition include social support, opportunity, economic possibility, hard work, and motivation, all of which may be independent
of gene-driven physiological factors. In the case of female athletes,
the percentage of people who have access to high-level sport is
markedly lower because of the history and lingering presence of
factors acting to keep women out of sport.
1. MacArthur DG, North KN. Genes and human elite athletic performance. Hum Genet. 2005;116(5):331339. PubMed doi:10.1007/
s00439-005-1261-8
2. Scott RA, Irving R, Irwin L, et al. ACTN3 and ACE genotypes in elite
Jamaican and US sprinters. Med Sci Sports Exerc. 2010;42(1):107
112. PubMed doi:10.1249/MSS.0b013e3181ae2bc0
3. Eynon N, Hanson ED, Lucia A, et al. Genes for elite power and sprint
performance: ACTN3 leads the way. Sports Med. 2013;43(9):803817.
PubMed doi:10.1007/s40279-013-0059-4
4. MacArthur DG, Seto JT, Raftery JM, et al. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive
selection in humans. Nat Genet. 2007;39(10):12611265. PubMed
doi:10.1038/ng2122
5. Papadimitriou ID, Lucia A, Pitsiladis YP, et al. ACTN3 R577X and
ACE I/D gene variants influence performance in elite sprinters: a multicohort study. BMC Genomics. 2016;17(1):285. PubMed doi:10.1186/
s12864-016-2462-3
6. Webborn N, Williams A, McNamee M, et al. Direct-to-consumer
genetic testing for predicting sports performance and talent identification: consensus statement. Br J Sports Med. 2015;49(23):14861491.
PubMed doi:10.1136/bjsports-2015-095343
7. Rankinen T, Fuku N, Wolfarth B, et al. No evidence of a common DNA
variant profile specific to world class endurance athletes. PLoS One.
2016;11(1):e0147330. PubMed doi:10.1371/journal.pone.0147330
8. Koch LG, Britton SL. Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol Genomics. 2001;5(1):4552.
PubMed
9. Wislff U, Najjar SM, Ellingsen O, et al. Cardiovascular risk factors
emerge after artificial selection for low aerobic capacity. Science.
2005;307(5708):418420. PubMed doi:10.1126/science.1108177
10. Williams AG, Folland JP. Similarity of polygenic profiles limits
the potential for elite human physical performance. J Physiol.
2008;586(1):113121. PubMed doi:10.1113/jphysiol.2007.141887
11. Berthelot G, Sedeaud A, Marck A, et al. Has athletic performance
reached its peak? Sports Med. 2015;45(9):12631271. PubMed
doi:10.1007/s40279-015-0347-2
12. Wilber RL, Pitsiladis YP. Kenyan and Ethiopian distance runners: what
makes them so good? Int J Sports Physiol Perform. 2012;7(2):92102.
PubMed doi:10.1123/ijspp.7.2.92